Department of Surgery, Indiana University, Indianapolis, IN, USA.
Ann Surg Oncol. 2011 Feb;18(2):468-71. doi: 10.1245/s10434-010-1353-0. Epub 2010 Sep 29.
To compare morbidity in patients with surgically implanted central venous ports that were placed in the subcutaneous tissues of the mid axillary line at the anterior border of the latissimus muscle (group A) versus the anterior chest wall (group C).
Between 2003 and 2007, a total of 183 patients with breast cancer were taken to the operating room for central venous port placement for delivery of chemotherapy. Port location was determined by patient and surgeon preference. Patient demographics were collected, and complications were evaluated by electronic medical record review. Complications identified included infection, thrombosis, port problems, and catheter problems. Basic descriptive statistics were generated. Patients with axillary ports were then compared to those with chest wall ports by appropriate t-tests or χ(2) tests.
During this period, 137 (75%) of 183 ports were placed in the axillary position. The complication rate was 10% (9% in group A vs. 13% in group C). There were 14 catheter-related complications and 5 port-related complications. There was no statistically significant difference in complications between the two groups (P = 0.45). Patients with axillary ports weighed less (mean 75.8 kg in group A vs. 84.9 kg in group C) and were more likely to have catheters placed in the internal jugular vein (82% in group A vs. 56% in group C).
There is no difference in rate or type of complications between axillary and chest wall port location. Subcutaneous ports can safely be placed in the mid axillary line. Axillary ports spare the patient the negative cosmetic outcomes of chest wall ports.
比较经腋前线胸大肌前缘皮下植入的中心静脉置管(A 组)与前胸部皮下植入的中心静脉置管(C 组)的发病率。
2003 年至 2007 年,共有 183 例乳腺癌患者接受中心静脉置管术,以进行化疗。置管位置由患者和外科医生的偏好决定。收集患者的人口统计学资料,并通过电子病历回顾评估并发症。确定的并发症包括感染、血栓形成、置管问题和导管问题。生成基本描述性统计数据。然后通过适当的 t 检验或卡方检验比较腋部置管患者与胸壁置管患者。
在此期间,183 个置管中有 137 个(75%)位于腋部。并发症发生率为 10%(A 组为 9%,C 组为 13%)。有 14 例与导管相关的并发症和 5 例与置管相关的并发症。两组之间并发症无统计学差异(P=0.45)。腋部置管患者的体重较轻(A 组平均 75.8 公斤,C 组平均 84.9 公斤),且更有可能在内颈静脉置管(A 组 82%,C 组 56%)。
腋部和胸壁置管的并发症发生率和类型无差异。皮下置管可安全地置于腋中线。腋部置管可避免患者出现胸壁置管的负面美容效果。